Most with Alzheimer’s disease, mild cognitive impairment would have been excluded from aducanumab...
Sep 16, 2021
Overall, 92.2, 91, and 85.5% of Medicare beneficiaries with Alzheimer’s disease-related disorders, Alzheimer’s disease, and mild cognitive impairment met at least one of the exclusion criteria.
15 percent of off-label antipsychotic use in assisted living may be inappropriate, but nursing home reduction...
By
Kimberly Bonvissuto
Sep 14, 2021
The rate of potentially inappropriate prescribing of drugs in assisted living is 15% for antipsychotics and 21% for antianxiety medications, according to the authors of a new study published in JAMDA,...
Increased regulation in assisted living affects resident hospitalizations: study
By
Kimberly Bonvissuto
Sep 09, 2021
Increased regulation of certified nursing assistants in assisted living and memory care communities is associated with fewer hospital admissions for residents, but more specific regulations for licensed...
U.S. News launches ‘Best Senior Living’ program
By
Lois A. Bowers
Sep 07, 2021
U.S. News & World Report has launched a “Best Senior Living” initiative with the goal of releasing inaugural listings for consumers in the first quarter of 2022. The program will cover individual...
More news for Tuesday, Aug. 31
Aug 31, 2021
Groups request extension for vaccine mandate in Maine … Senior housing providers can take action to protect older adults from the end of eviction moratorium … Multiple defendants indicted in ‘grandparent...
Widespread pain tied to dementia, Alzheimer’s disease, stroke
Aug 17, 2021
After adjustment for multiple variables, widespread pain appeared to increase subsequent risk.
Global dementia cases projected to top 152 million in 2050
Jul 29, 2021
Increases in cases were mainly due to population growth and aging, with the relative importance of these factors varying by region.
Relapse risk for psychosis in dementia lower with continued pimavanserin
Jul 22, 2021
The findings were seen in a double-blind, randomized, placebo-controlled discontinuation trial that was stopped early for efficacy.
More news for Wednesday, July 14
By
Alicia Lasek
Jul 14, 2021
Medicare to weigh national coverage for Aduhelm, other Alzheimer’s treatments … Neurologists issue ethical guidance for dementia diagnosis and care … Helping seniors hear better may slow decline...
Medicare mulls coverage for controversial drug for Alzheimer’s disease
Jul 13, 2021
CMS says a final decision on coverage is not likely until next spring.